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Microsporidia are the fungi which have 1200 species and 400 genera. They are ubiquitous and may infect animals, fish, insects as well as humans [1]. Human 
infection is uncommon and only seen in the immunocompromised 
individual. The most commonly involved systems in human are 
the gastrointestinal, urinary, and respiratory systems.
We present this case as the involvement of skeletal muscle 
by microsporidia is very rare and documented only in isolated 
case reports since 1985 [2]. Furthermore, we want to highlight 
certain specific hurdles such as the development of immune 
reconstitution inflammatory syndrome (IRIS) during therapy.
CASE REPORT
A 40-year-old female presented with the complaint of pain in both 
the legs for the past 1 month, especially in both calf muscles. 
The pain was of a continuous, aching character aggravated with 
movement and not relieved completely even by analgesics. The 
patient was unable to walk for the same duration. On further 
inquiry, it was found that she was also unable to stand from 
squatting for the past 1½ months. She also complained of tingling 
sensations in her feet. She had been admitted to a local hospital 
6 months back with severe shortness of breath for 7 days along with 
a history of intermittent low-grade evening rise of temperature 
and cough for 15 days. On subsequent investigations, she was 
diagnosed to be immunocompromised with Pneumocystis jiroveci 
pneumonia. At that time, her CD4 count was only 7/µl. She was 
non-diabetic, non-hypertensive, and euthyroid. There was no 
history of imbalance, vertigo, headache, vomiting, convulsion, 
back pain, diurnal variation of weakness, or history suggestive of 
cranial nerve disorders. Bladder and bowel habits were normal.
On general examination, the patient was alert, conscious, 
and well oriented. She had poor nutrition (body mass index or 
BMI 15.3 kg/m2) and pallor. The pulse was 96/min, regular, 
normal volume, and BP was 100/60 mmHg in the right arm in 
the supine posture. Respiratory rate was 16/min, which was of 
thoracoabdominal. Tenderness was present over both calf muscle 
regions. Examination of the nervous system revealed decreased 
tone in all four limbs; power was 4/5 in distal muscles and (4-)/5 
in proximal muscles in all the four limbs. All jerks were preserved 
except both the ankle jerks. There was some distal sensory loss 
bilaterally in the lower limbs.
On investigations, hemoglobin was 6.3 g/dl, packed cell volume 
22.8%, mean corpuscular volume 108.1 fl, mean corpuscular 
hemoglobin 29.9 pg/dl, and mean cell hemoglobin concentration 
27.6 g/dl. Peripheral blood smear showed macrocytic normochromic 
anemia with anisopoikilocytosis. Complete blood count was 
otherwise non-contributory. Electrolytes level, liver function test, 
renal function test, and lipid profile tests were found normal. Serum 
phosphate was 4.0 mg/dl, calcium was 7.8 mg/dl, and Vitamin D3 
was 43.53 ng/ml. Free T4 was 1.02 ng/dl, and thyroid-stimulating 
hormone was 13.2 µIU/ml. The serum creatine phosphokinase was 
498 U/L (normal level up to 167), and C-reactive protein 6.58 mg/dl 
(<0.3 mg/dl). Antinuclear antibodies was negative, p-ANCA- 4+, 
but the levels of myeloperoxidase and PR3 were negative. Serum 
folate level was 1.73 ng/ml (2–20 ng/ml), and serum Vitamin B12 
was >200 ng/ml (200–900 ng/ml). Latest CD4 cell count was 
found to be 50 cells/µl. Ultrasonogram (USG) of both the legs 
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revealed heterogeneous hypoechoic lesions noted in between calf 
muscle region without any obvious collection. Magnetic resonance 
imaging (MRI) of both the lower limbs showed extensive muscle 
edema with shaggy intermuscular planes in calf muscles and thigh 
as well. No marrow edema was found. Normal cortices of bones 
were reported (Figs. 1 and 2).
Electromyogram (EMG) was suggestive of the myopathic 
pattern. Antibody for myositis, i.e., anti-Jo 1 and overlap of 
systemic sclerosis and myositis, i.e., anti PM/Scl were sent 
but came to be non-contributory. Muscle biopsy was done and 
histopathology report of formalin-fixed skeletal muscle showed 
longitudinally, obliquely, and transversely cut fibers. Myofibers 
were polygonal with internalized nuclei. The fascicular 
architecture was partly effaced by fat infiltration. There was 
marked edema separating the muscle fibers. Polyfocal necrosis 
and myophagocytosis were present. Scattered atrophic fibers 
were present. Several of the myofibers were bloated and showed 
clusters of pale oval bodies (spores) 2–3 µ wide and 3–5 um 
in length in the sarcoplasm. These microsporidial spores were 
highlighted on special stains and were of red color (weak acid 
fast), black color (Grocott-Gomori’s methenamine silver stain 
[GMS]), and magenta color (Periodic Acid Schiff). The spores 
showed dark staining at the narrow end or waistband area close to 
the tip. There was no evidence of budding in these spores. Mild 
interstitial and perivascular lymphoplasmacytic and histiocytic 
inflammatory infiltrate was seen. There were no eosinophils, giant 
cells, or neutrophils. The inflammatory response to the pathogen 
was minimal considering the immunocompromised status of the 
patient. Masson’s trichrome stain highlighted the microspoidial 
spores as red color. There were mild endomysial creeping fibrosis 
and focal fat infiltration.
Based on the above-mentioned clinical, radiological, and 
histological investigations, a diagnosis of myositis and IRIS was 
made and the patient was put on oral albendazole therapy along with 
the antiretroviral therapy (ART) and sulfadiazine pyrimethamine. 
Unfortunately, the patient suddenly developed acute onset, 
progressive weakness of all four limbs after 7 days. Deep tendon 
reflexes were absent in all four limbs. No sensory involvement or 
bladder and bowel involvement was found. Examination of the 
patient showed acute onset areflexic quadriparesis without any 
sensory and bladder and bowel involvement. Nerve conduction 
study documented acute motor axonal polyradiculoneuropathy.
The sequence of events led to the marked clinical deterioration 
of the patient. She was put on intravenous immunoglobulin 
G (IVIG) after consulting neurologist. The improvement 
was suboptimal even though the patient was on albendazole, 
sulfadiazine pyrimethamine IVIG, and ART. The possibility of 
IRIS was considered, and a cautious dose of steroids was added. 
Thereafter, the patient started to improve significantly. The patient 
was found asymptomatic on further follow-up at 3 months.
DISCUSSION
The rapid decrease in viral load after starting ART leads to 
the phenomenon of IRIS comprising clinical deterioration, 
opportunistic infections, and autoimmune phenomena. The CD4 
count of our patient had improved from 7 to 50 in 6 months, but 
she deteriorated due to the acute inflammatory demyelinating 
polyneuropathy (AIDP) and microsporidial infection. 
Microsporidia are obligate intracellular parasites now classified 
as fungi. The sources of fungal spores are water, undercooked 
food, and pets [3]. The majority of microsporidial infections 
involve the small gut gallbladder, sinuses, cornea, urinary, and 
respiratory tracts [4]. Involvement of muscles by this organism is 
extremely rare.
Figure 1: Magnetic resonance imaging of calf muscles’ longitudinal 
cut showing extensive muscle edema with shaggy intermuscular 
planes
Figure 2: Magnetic resonance imaging of thigh muscles’ transverse 
cut showing patchy areas of muscle edema and no marrow edema 
with normal cortices
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The first case was reported in an AIDS patient in 1985 [2].
Since then, isolated anecdotal reports have been published 
regarding microsporidial myopathy. The incriminated species are 
Trichopleistophora hominis, Pleistophora ronneafiei, Brachiola 
vesicularum, and Tubulinesema acridophagus [5-9]. No specific 
culture or serological test is available, and species are the only 
electron microscopically identified.
On presentation, our initial impression of the patient 
was that her muscle involvement was a part of the human 
immunodeficiency virus spectrum. However, the new onset 
of severe myalgia and weakness in 2 months led us to look for 
other causes. Marked pain and tenderness of calves may be 
due to pyomyositis, inflammatory muscle disease, deep venous 
thrombosis, and painful neuropathy [10-12]. USG Doppler study 
of the legs gave us the first clue to look for myositis which was 
later confirmed by MRI, EMG, and biopsy.
CONCLUSION
Treatment of the immunocompromised patients even after 
diagnosis poses many challenges to the clinician. The development 
of AIDP after starting therapy for microsporidiosis as a result 
of IRIS demonstrates the immense complexity in the treatment 
strategy of AIDS patients where a fine balance is to be struck to 
get optimum results.
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